These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27157128)

  • 1. Identifying possible sites for antibody neutralization escape: Implications for unique functional properties of the C-terminal tail of Human Immunodeficiency Virus Type 1 gp41.
    Lu Z; Huang Y; Tan Y; Yu Y; Wang J; Chen YH
    Immunol Lett; 2016 Jul; 175():21-30. PubMed ID: 27157128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41.
    Kalia V; Sarkar S; Gupta P; Montelaro RC
    J Virol; 2005 Feb; 79(4):2097-107. PubMed ID: 15681412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.
    Reh L; Magnus C; Kadelka C; Kühnert D; Uhr T; Weber J; Morris L; Moore PL; Trkola A
    PLoS Pathog; 2018 Jan; 14(1):e1006825. PubMed ID: 29370298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
    Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.
    Blish CA; Nguyen MA; Overbaugh J
    PLoS Med; 2008 Jan; 5(1):e9. PubMed ID: 18177204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Single Substitution in gp41 Modulates the Neutralization Profile of SHIV during In Vivo Adaptation.
    Wang Q; Liu L; Ren W; Gettie A; Wang H; Liang Q; Shi X; Montefiori DC; Zhou T; Zhang L
    Cell Rep; 2019 May; 27(9):2593-2607.e5. PubMed ID: 31141685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function.
    Hollier MJ; Dimmock NJ
    Virology; 2005 Jul; 337(2):284-96. PubMed ID: 15913700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twist in the Tail: Escape from HIV Neutralising Antibodies at a Single Site Confers Broad Susceptibility to Others.
    Wheatley AK; Kent SJ
    EBioMedicine; 2016 Oct; 12():14-15. PubMed ID: 27667177
    [No Abstract]   [Full Text] [Related]  

  • 11. Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1.
    McLain L; Brown JL; Cheung L; Reading SA; Parry C; Jones TD; Cleveland SM; Dimmock NJ
    Arch Virol; 2001; 146(1):157-66. PubMed ID: 11266210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.
    Cleveland SM; McLain L; Cheung L; Jones TD; Hollier M; Dimmock NJ
    J Gen Virol; 2003 Mar; 84(Pt 3):591-602. PubMed ID: 12604810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodies.
    O'Rourke SM; Schweighardt B; Phung P; Mesa KA; Vollrath AL; Tatsuno GP; To B; Sinangil F; Limoli K; Wrin T; Berman PW
    J Virol; 2012 Nov; 86(22):12105-14. PubMed ID: 22933284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins.
    Visciano ML; Diomede L; Tagliamonte M; Tornesello ML; Asti V; Bomsel M; Buonaguro FM; Lopalco L; Buonaguro L
    Vaccine; 2011 Jul; 29(31):4903-12. PubMed ID: 21596074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies.
    Shen G; Upadhyay C; Zhang J; Pan R; Zolla-Pazner S; Kong XP; Hioe CE
    PLoS One; 2015; 10(10):e0141233. PubMed ID: 26491873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
    Witt KC; Castillo-Menendez L; Ding H; Espy N; Zhang S; Kappes JC; Sodroski J
    PLoS One; 2017; 12(2):e0170672. PubMed ID: 28151945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.
    Cerutti N; Loredo-Varela JL; Caillat C; Weissenhorn W
    Curr Opin HIV AIDS; 2017 May; 12(3):250-256. PubMed ID: 28422789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization.
    Salimi H; Johnson J; Flores MG; Zhang MS; O'Malley Y; Houtman JC; Schlievert PM; Haim H
    J Biol Chem; 2020 Jan; 295(2):348-362. PubMed ID: 31757809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS; Lee SF; Wang CT
    J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion.
    Narasimhulu VGS; Bellamy-McIntyre AK; Laumaea AE; Lay CS; Harrison DN; King HAD; Drummer HE; Poumbourios P
    J Biol Chem; 2018 Apr; 293(16):6099-6120. PubMed ID: 29496992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.